BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38562856)

  • 1. Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis.
    Widder S; Carmody L; Opron K; Kalikin L; Caverly L; LiPuma J
    Res Sq; 2024 Mar; ():. PubMed ID: 38562856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis.
    Widder S; Opron K; Carmody LA; Kalikin LM; Caverly LJ; LiPuma JJ
    bioRxiv; 2023 Jul; ():. PubMed ID: 37546739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in airway bacterial communities occur soon after initiation of antibiotic treatment of pulmonary exacerbations in cystic fibrosis.
    Carmody LA; Kalikin LM; VanDevanter DR; Li G; Opron K; Simon RH; Caverly LJ; LiPuma JJ
    J Cyst Fibros; 2022 Sep; 21(5):766-768. PubMed ID: 35667975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations.
    Zemanick ET; Harris JK; Wagner BD; Robertson CE; Sagel SD; Stevens MJ; Accurso FJ; Laguna TA
    PLoS One; 2013; 8(4):e62917. PubMed ID: 23646159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications and characterization of Group A Streptoccoccus infections in adults with cystic fibrosis.
    Skolnik K; Nguyen A; Somayaji R; Thornton CS; Waddell B; Surette MG; Rabin HR; Parkins MD
    BMC Pulm Med; 2015 Dec; 15():161. PubMed ID: 26651825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Resolution Longitudinal Dynamics of the Cystic Fibrosis Sputum Microbiome and Metabolome through Antibiotic Therapy.
    Raghuvanshi R; Vasco K; Vázquez-Baeza Y; Jiang L; Morton JT; Li D; Gonzalez A; DeRight Goldasich L; Humphrey G; Ackermann G; Swafford AD; Conrad D; Knight R; Dorrestein PC; Quinn RA
    mSystems; 2020 Jun; 5(3):. PubMed ID: 32576651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ecological Succession of Polymicrobial Communities in the Cystic Fibrosis Airways.
    Khanolkar RA; Clark ST; Wang PW; Hwang DM; Yau YCW; Waters VJ; Guttman DS
    mSystems; 2020 Dec; 5(6):. PubMed ID: 33262240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response.
    Lam JC; Somayaji R; Surette MG; Rabin HR; Parkins MD
    BMC Infect Dis; 2015 Mar; 15():145. PubMed ID: 25887462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Clinical Impact of Respiratory Viral Infections from the STOP2 Study of Cystic Fibrosis Pulmonary Exacerbations.
    Thornton CS; Caverly LJ; Kalikin LM; Carmody LA; McClellan S; LeBar W; Sanders DB; West NE; Goss CH; Flume PA; Heltshe SL; VanDevanter DR; LiPuma JJ
    Ann Am Thorac Soc; 2024 Apr; 21(4):595-603. PubMed ID: 37963297
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of Antibiotics on the Lung Microbiome and Lung Function in Children With Cystic Fibrosis 1 Year After Hospitalization for an Initial Pulmonary Exacerbation.
    Inam Z; Felton E; Burrell A; Chaney H; Sami I; Koumbourlis AC; Freishtat RJ; Zemanick ET; Crandall KA; Hahn A
    Open Forum Infect Dis; 2022 Sep; 9(9):ofac466. PubMed ID: 36168550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low Diversity and Instability of the Sinus Microbiota over Time in Adults with Cystic Fibrosis.
    Armbruster CR; Li K; Kiedrowski MR; Zemke AC; Melvin JA; Moore J; Atteih S; Fitch AC; DuPont M; Manko CD; Weaver ML; Gaston JR; Alcorn JF; Morris A; Methé BA; Lee SE; Bomberger JM
    Microbiol Spectr; 2022 Oct; 10(5):e0125122. PubMed ID: 36094193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations.
    Fodor AA; Klem ER; Gilpin DF; Elborn JS; Boucher RC; Tunney MM; Wolfgang MC
    PLoS One; 2012; 7(9):e45001. PubMed ID: 23049765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Elusive Role of Airway Infection in Cystic Fibrosis Exacerbation.
    Caverly LJ; VanDevanter DR
    J Pediatric Infect Dis Soc; 2022 Sep; 11(Supplement_2):S40-S45. PubMed ID: 36069900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial Stewardship in Cystic Fibrosis.
    Lloyd EC; Cogen JD; Maples H; Bell SC; Saiman L
    J Pediatric Infect Dis Soc; 2022 Sep; 11(Supplement_2):S53-S61. PubMed ID: 36069899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic Corticosteroids in the Management of Pediatric Cystic Fibrosis Pulmonary Exacerbations.
    Davis CS; Faino AV; Onchiri F; Gibson RL; Merjaneh L; Ramsey BW; Rosenfeld M; Cogen JD
    Ann Am Thorac Soc; 2023 Jan; 20(1):75-82. PubMed ID: 36044723
    [No Abstract]   [Full Text] [Related]  

  • 17. Improved recognition of lung function decline as signal of cystic fibrosis pulmonary exacerbation: a Cystic Fibrosis Learning Network Innovation Laboratory quality improvement initiative.
    List R; Solomon G; Bichl S; Horton BJ; Shen S; Corcoran B; Sadeghi H; Britto MT; Ren C; Albon D;
    BMJ Open Qual; 2023 Dec; 12(4):. PubMed ID: 38154821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis.
    Schultz A; McLeod C; Berry S; Marsh J; McKenzie A; Messer M; Wood J; Saville B; Jaffe A; Ranganathan S; Stick S; Wark P; Webb S; Snelling T
    Trials; 2023 Mar; 24(1):211. PubMed ID: 36949472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Winogradsky-based culture system shows an association between microbial fermentation and cystic fibrosis exacerbation.
    Quinn RA; Whiteson K; Lim YW; Salamon P; Bailey B; Mienardi S; Sanchez SE; Blake D; Conrad D; Rohwer F
    ISME J; 2015 Mar; 9(4):1024-38. PubMed ID: 25514533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild Cystic Fibrosis Lung Disease Is Associated with Bacterial Community Stability.
    Hampton TH; Thomas D; van der Gast C; O'Toole GA; Stanton BA
    Microbiol Spectr; 2021 Sep; 9(1):e0002921. PubMed ID: 34232099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.